103 related articles for article (PubMed ID: 3619434)
1. Selective inhibitory effects of (S)-9-(3-hydroxy-2-phosphonyl-methoxypropyl) adenine and 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil on seal herpesvirus (phocid herpesvirus 1) infection in vitro.
Osterhaus AD; Groen J; De Clercq E
Antiviral Res; 1987 May; 7(4):221-6. PubMed ID: 3619434
[TBL] [Abstract][Full Text] [Related]
2. Ab initio studies of the antiviral drug 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl) thymine.
Sapse AM; Snyder G
Cancer Invest; 1985; 3(2):115-21. PubMed ID: 3995376
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of various 1-beta-D-arabinofuranosyl-E-5-halogenovinyluracils and E-5-bromovinyl-2'-deoxyuridine against salmon herpes virus, Oncorhynchus masou virus (OMV).
Suzuki S; Machida H; Saneyoshi M
Antiviral Res; 1987 Feb; 7(2):79-86. PubMed ID: 3034148
[TBL] [Abstract][Full Text] [Related]
4. Nucleosides. 146. 1-Methyl-5-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil, the C-nucleoside isostere of the potent antiviral agent 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)thymine (FMAU). Studies directed toward the synthesis of 2'-deoxy-2'-substituted arabino nucleosides. 6.
Pankiewicz KW; Nawrot B; Gadler H; Price RW; Watanabe KA
J Med Chem; 1987 Dec; 30(12):2314-6. PubMed ID: 2824777
[TBL] [Abstract][Full Text] [Related]
5. 1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil. A highly selective antiherpes simplex agent.
Mansuri MM; Ghazzouli I; Chen MS; Howell HG; Brodfuehrer PR; Benigni DA; Martin JC
J Med Chem; 1987 May; 30(5):867-71. PubMed ID: 3033244
[TBL] [Abstract][Full Text] [Related]
6. Effect of acyclovir on the uptake of 131I-labelled 1-(2'fluoro-2'-deoxy-beta-D-arabinofuranosyl)-5-iodouracil in herpes infected cells.
Tovell DR; Yacyshyn HP; Misra HK; Knaus EE; Wiebe LI; Samuel J; Gill MJ; Tyrrell DL
J Med Virol; 1987 Jun; 22(2):183-8. PubMed ID: 3039053
[TBL] [Abstract][Full Text] [Related]
7. Equine herpes virus 1 and pseudorabies virus resistance to 2'-fluoropyrimidine analogs and to bromovinyldeoxyuridine: implications for dTMP kinase activity.
Veerisetty V; Balasubramaniam NK; Gentry GA
Acta Virol; 1990 Dec; 34(6):568-73. PubMed ID: 1983184
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against newly isolated clinical varicella-zoster virus strains.
Baba M; Konno K; Shigeta S; De Clercq E
Eur J Clin Microbiol; 1987 Apr; 6(2):158-60. PubMed ID: 3036498
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus.
Schinazi RF; Peters J; Sokol MK; Nahmias AJ
Antimicrob Agents Chemother; 1983 Jul; 24(1):95-103. PubMed ID: 6625559
[TBL] [Abstract][Full Text] [Related]
10. Activity of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil against simian varicella virus infections in African green monkeys.
Soike KF; Cantrell C; Gerone PJ
Antimicrob Agents Chemother; 1986 Jan; 29(1):20-5. PubMed ID: 3729332
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of acyclic nucleoside phosphonates against herpes virus replication.
Neyts J; De Clercq E
Biochem Pharmacol; 1994 Jan; 47(1):39-41. PubMed ID: 8311844
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibitory effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 2'-nor-cyclic GMP on adenovirus replication in vitro.
Baba M; Mori S; Shigeta S; De Clercq E
Antimicrob Agents Chemother; 1987 Feb; 31(2):337-9. PubMed ID: 3566256
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on woodchuck hepatitis virus replication in chronically infected woodchucks.
Fourel I; Hantz O; Watanabe KA; Jacquet C; Chomel B; Fox JJ; Trepo C
Antimicrob Agents Chemother; 1990 Mar; 34(3):473-5. PubMed ID: 2334160
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of simian varicella virus infection of monkeys by 1-(2-deoxy-2- fluoro-1-beta-D-arabinofuranosyl)-5-ethyluracil (FEAU) and synergistic effects of combination with human recombinant interferon-beta.
Soike KF; Chou TC; Fox JJ; Watanabe KA; Gloff CA
Antiviral Res; 1990 Apr; 13(4):165-74. PubMed ID: 2166466
[TBL] [Abstract][Full Text] [Related]
15. Isolation of equine herpesvirus-1 mutants in the presence of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine: demonstration of resistance in vitro and in vivo.
Field HJ; Awan AR; de la Fuente R
Antiviral Res; 1991 Jul; 16(1):29-39. PubMed ID: 1663728
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-hepatitis B virus activity of 9-(2-deoxy-2-fluoro-beta-L-arabinofuranosyl) purine nucleosides.
Ma T; Lin JS; Newton MG; Cheng YC; Chu CK
J Med Chem; 1997 Aug; 40(17):2750-4. PubMed ID: 9276020
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus: inhibition of replication by three new drugs.
Lin JC; Smith MC; Cheng YC; Pagano JS
Science; 1983 Aug; 221(4610):578-9. PubMed ID: 6306771
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) and related compounds.
Machida H; Sakata S
Antiviral Res; 1984 Jun; 4(3):135-41. PubMed ID: 6089657
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of the anti-hepatitis B nucleoside analog 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) by human cytosolic and mitochondrial thymidine kinase and implications for cytotoxicity.
Wang J; Eriksson S
Antimicrob Agents Chemother; 1996 Jun; 40(6):1555-7. PubMed ID: 8726039
[TBL] [Abstract][Full Text] [Related]
20. Structures of metabolites isolated from urine of mice treated with the antiviral agent, 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-methyluracil.
Feinberg A; Vidal PM; Fox JJ; Watanabe KA; Chun MW; Field FH; Bencsath A; Chait B; Philips FS
Drug Metab Dispos; 1984; 12(6):784-6. PubMed ID: 6150831
[No Abstract] [Full Text] [Related]
[Next] [New Search]
